Trade now with Barclays Stockbrokers
09-May-24 |
Buy |
Damian Sanders |
63.55p | 312,500 |
£198,593.75 |
25-Apr-24 |
Buy |
Helen Jones |
63.10p | 30,000 |
£18,930.00 |
09-May-24 |
Buy |
Damian Sanders |
63.55p | 312,500 |
£198,593.75 |
25-Apr-24 |
Buy |
Helen Jones |
63.10p | 30,000 |
£18,930.00 |
Matthew Moulding |
183,850,547 |
£118,399,752 |
Charles Allen |
2,400,000 |
£1,545,600 |
John Gallemore |
682,947 |
£439,818 |
Damian Sanders |
334,426 |
£215,370 |
Susan Jane Farr |
40,897 |
£26,338 |
Helen Jones |
30,000 |
£19,320 |
Sofina Capital S.A |
115,542,400 |
£74,409,306 |
Balderton Capital IV, L.P |
96,947,470 |
£62,434,171 |
Qatar Investment Authority |
95,148,959 |
£61,275,930 |
Merian Global Investors |
86,972,130 |
£56,010,052 |
SB Northstar LP |
80,621,797 |
£51,920,437 |
Jupiter Fund Management plc |
62,034,208 |
£39,950,030 |
T. Rowe Price |
60,908,595 |
£39,225,135 |
16:35 |
206,397 @ 64.40p |
16:35 |
1 @ 64.40p |
16:35 |
7,047 @ 64.40p |
16:35 |
1,331 @ 64.40p |
16:35 |
3,559 @ 64.40p |
CEO |
Matthew Moulding |
CFO |
Damian Sanders |
Chair |
Charles Allen |
Top of Page
You are here:
research